Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.

A Peyman1, V Wehner, J Knolle

  • 1Hoechst Marion Roussel Deutschland GmhH, Frankfurt, Germany. anusch.peyman@hmrag.com

Bioorganic & Medicinal Chemistry Letters
|February 15, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of disorder-free localization using a (2+1)D lattice gauge theory on a quantum processor.

Science (New York, N.Y.)·2026
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026

Researchers synthesized hydantoin-based compounds that act as integrin antagonists. These molecules show specific binding to alpha(v)beta3 integrins, highlighting key structural features for selective drug design.

Area of Science:

  • Medicinal Chemistry
  • Biochemistry
  • Pharmacology

Background:

  • Integrins, such as alpha(v)beta3 and alpha(IIb)beta3, are cell surface receptors involved in various physiological and pathological processes.
  • Selective antagonists targeting specific integrin subtypes are crucial for developing targeted therapies.

Purpose of the Study:

  • To synthesize and characterize novel RGD mimetic compounds based on a hydantoin scaffold.
  • To investigate the structure-activity relationships governing the selectivity of these compounds for alpha(v)beta3 integrin over alpha(IIb)beta3 integrin.

Main Methods:

  • Chemical synthesis of a series of hydantoin derivatives.
  • In vitro assays to evaluate integrin binding affinity and selectivity.

Main Results:

Related Experiment Videos

  • Successful synthesis of hydantoin-based RGD mimetics.
  • Identification of key structural determinants for alpha(v)beta3 integrin selectivity.
  • Demonstrated importance of the Arg-mimetic, linker length, and lipophilic side chain.

Conclusions:

  • The hydantoin scaffold can accommodate structural modifications to achieve selective alpha(v)beta3 antagonism.
  • Understanding these structural requirements facilitates the rational design of targeted integrin therapies.